• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种利尿剂对胆红素与人白蛋白结合的置换作用。

Displacement of bilirubin from human albumin by three diuretics.

作者信息

Wennberg R P, Rasmussen F, Ahlfors C E

出版信息

J Pediatr. 1977 Apr;90(4):647-50. doi: 10.1016/s0022-3476(77)80393-4.

DOI:10.1016/s0022-3476(77)80393-4
PMID:839388
Abstract

The interaction of three diuretics with bilirubin-albumin complexes was studied using the peroxidase assay, erythrocyte uptake, and sephadex gel filtration. On a molar basis, each diuretic was as potent or more potent than sulfisoxazole in displacing bilirubin from albumin. Furosemide and ethacrynic acid, when used at the recommended dosage (1 mg/kg), would probably not produce a significant increase in free bilirubin in most infants. Chlorothiazide could introduce a significant risk to jaundiced infants because of the higher dosage required.

摘要

使用过氧化物酶测定法、红细胞摄取法和葡聚糖凝胶过滤法研究了三种利尿剂与胆红素-白蛋白复合物的相互作用。以摩尔为基础,每种利尿剂在从白蛋白置换胆红素方面与磺胺异恶唑一样有效或更有效。当按推荐剂量(1毫克/千克)使用时,速尿和依他尼酸在大多数婴儿中可能不会使游离胆红素显著增加。由于所需剂量较高,氯噻嗪可能会给黄疸婴儿带来重大风险。

相似文献

1
Displacement of bilirubin from human albumin by three diuretics.三种利尿剂对胆红素与人白蛋白结合的置换作用。
J Pediatr. 1977 Apr;90(4):647-50. doi: 10.1016/s0022-3476(77)80393-4.
2
The displacement of bilirubin from albumin by furosemide.速尿使胆红素从白蛋白上解离。
J Pediatr. 1977 Apr;90(4):642-6. doi: 10.1016/s0022-3476(77)80392-2.
3
The effect of paraben preservatives on albumin binding of bilirubin.对羟基苯甲酸酯类防腐剂对胆红素白蛋白结合的影响。
J Pediatr. 1976 Sep;89(3):475-8. doi: 10.1016/s0022-3476(76)80557-4.
4
[Study of the binding of diuretics by serum proteins according to changes in tryptophan fluorescence].[根据色氨酸荧光变化研究血清蛋白与利尿剂的结合]
Farmakol Toksikol. 1989 May-Jun;52(3):40-3.
5
Protein binding and bilirubin displacing properties of bumetanide and furosemide.布美他尼和呋塞米的蛋白结合及胆红素置换特性。
J Clin Pharmacol. 1982 Nov-Dec;22(11-12):551-6. doi: 10.1002/j.1552-4604.1982.tb02648.x.
6
Reversible binding of ethacrynic acid to human serum albumin: difference circular dichroism study.依他尼酸与人血清白蛋白的可逆结合:圆二色性差异研究。
Chirality. 1999;11(1):33-8. doi: 10.1002/(SICI)1520-636X(1999)11:1<33::AID-CHIR6>3.0.CO;2-U.
7
[Mechanism of action of diuretics studied by a fluorescent probe method].[用荧光探针法研究利尿剂的作用机制]
Farmakol Toksikol. 1983 Nov-Dec;46(6):79-83.
8
Bilirubin-displacing effect of furosemide and sulfisoxazole. An in vitro and in vivo study in neonatal serum.
Dev Pharmacol Ther. 1983;6(4):230-8. doi: 10.1159/000457309.
9
Displacement of bilirubin from albumin by indomethacin.吲哚美辛使胆红素从白蛋白上解离。
J Clin Pharmacol. 1978 Oct;18(10):477-81. doi: 10.1002/j.1552-4604.1978.tb01575.x.
10
Loop-acting diuretics do not bind to Tamm-Horsfall urinary glycoprotein.袢利尿剂不与Tamm-Horsfall尿糖蛋白结合。
Clin Sci (Lond). 1987 Sep;73(3):305-10. doi: 10.1042/cs0730305.

引用本文的文献

1
Impact of Protein Binding Capacity and Daily Dosage of a Drug on Total Serum Bilirubin Levels in Susceptible Infants.药物的蛋白结合能力和日剂量对易感婴儿总血清胆红素水平的影响
Children (Basel). 2023 May 24;10(6):926. doi: 10.3390/children10060926.
2
Amount of Cycloserine Emanating from Terizidone Metabolism and Relationship with Hepatic Function in Patients with Drug-Resistant Tuberculosis.特立齐酮代谢产生的环丝氨酸量与耐药结核病患者肝功能的关系。
Drugs R D. 2019 Sep;19(3):289-296. doi: 10.1007/s40268-019-00281-4.
3
Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants.
临床状况对极低出生体重儿血浆总胆红素和未结合胆红素与死亡或不良神经发育结局之间关系的影响。
Acta Paediatr. 2010 May;99(5):673-678. doi: 10.1111/j.1651-2227.2010.01688.x. Epub 2010 Jan 25.
4
Diuretics in pediatrics : current knowledge and future prospects.儿科利尿剂:当前认知与未来展望
Paediatr Drugs. 2006;8(4):245-64. doi: 10.2165/00148581-200608040-00004.
5
Pharmacokinetics of diuretics and methylxanthines in the neonate.新生儿中利尿剂和甲基黄嘌呤的药代动力学
Eur J Clin Pharmacol. 1980 Jul;18(1):55-63. doi: 10.1007/BF00561479.
6
Pharmacokinetics of furosemide in neonates.
Eur J Clin Pharmacol. 1982;22(1):39-45. doi: 10.1007/BF00606423.
7
Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement.新生儿胆红素毒性。核黄疸综述及药物诱导胆红素置换的影响。
Clin Pharmacokinet. 1987 Jul;13(1):26-50. doi: 10.2165/00003088-198713010-00002.
8
Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).新生儿药物生物转化原理。药代动力学-药效学界面的批判性评估(第二部分)
Clin Pharmacokinet. 1988 May;14(5):261-86. doi: 10.2165/00003088-198814050-00001.
9
Clinical pharmacokinetics of frusemide.
Clin Pharmacokinet. 1979 Jul-Aug;4(4):279-96. doi: 10.2165/00003088-197904040-00002.